down arrow

Sudarshan Pharma

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE00TV01023
  • NSEID:
  • BSEID: 543828
INR
29.53
-0.6 (-1.99%)
BSENSE

Apr 11, 12:37 PM

BSE+NSE Vol: 16000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Sudarshan Pharma Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
Profit Before Tax
15.00
9.00
7.00
3.00
1.00
Adjustment
9.00
5.00
4.00
3.00
3.00
Changes In working Capital
-16.00
-42.00
-13.00
-3.00
-4.00
Cash Flow after changes in Working Capital
8.00
-26.00
-2.00
3.00
0.00
Cash Flow from Operating Activities
6.00
-28.00
-3.00
2.00
0.00
Cash Flow from Investing Activities
-5.00
-25.00
-1.00
-1.00
-2.00
Cash Flow from Financing Activities
-12.00
65.00
4.00
-1.00
0.00
Net Cash Inflow / Outflow
-11.00
11.00
-1.00
0.00
-2.00
Opening Cash & Cash Equivalents
11.00
0.00
1.00
1.00
3.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
11.00
0.00
1.00
1.00
Compare Cash Flow Results of Sudarshan Pharma
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
15.23
2399.36
-2,384.00
-99.37%
Adjustment
9.4
212.2
-203.00
-95.57%
Changes In working Capital
-16.46
20.42
-36.00
-180.61%
Cash Flow after changes in Working Capital
8.17
2631.98
-2,623.00
-99.69%
Cash Flow from Operating Activities
6.01
2152.45
-2,146.00
-99.72%
Cash Flow from Investing Activities
-5.49
-2080.52
2,075.00
99.74%
Cash Flow from Financing Activities
-12.1
5.27
-17.00
-329.60%
Net Cash Inflow / Outflow
-11.58
77.19
-88.00
-115.00%
Opening Cash & Cash Equivalents
11.72
304.82
-293.00
-96.16%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0.14
382.01
-382.00
-99.96%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 120.88% vs -653.66% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
6.01
-28.79
120.88%